Literature DB >> 25332547

Symptomatic Acquired Haemophilia Due to Circulating Antibodies Against Both Factor VIII and IX in a Non-haemophiliac Patient.

Sharat Damodar1, Prashantha Bhat1, Sitalakshmi Balasubramaniam2.   

Abstract

Acquired haemophilia is a very rare condition, occurring in less than 2 per million populations. This condition is caused commonly by acquired antibodies against factor VIII and rarely by antibodies against factor IX. Here we describe an extremely rare presentation of idiopathic acquired haemophilia in an otherwise healthy male patient, caused by simultaneous occurrence of circulating antibodies against both factor VIII and IX.

Entities:  

Keywords:  Acquired haemophilia; Factor IX inhibitor; Factor VIII inhibitor

Year:  2013        PMID: 25332547      PMCID: PMC4192245          DOI: 10.1007/s12288-013-0270-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

Review 1.  Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

Authors:  Julio Delgado; Victor Jimenez-Yuste; Fernando Hernandez-Navarro; Ana Villar
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

2.  Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.

Authors:  F Carmassi; C Giannarelli; A De Giorgi; F De Negri
Journal:  Haemophilia       Date:  2007-01       Impact factor: 4.287

3.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

4.  Inhibitors of factors VIII and IX in a child with Henoch-Schönlein syndrome.

Authors:  J B Gouyon; F Seiller; X Deries; M Alison; J L Lorenzini; E Devilliers
Journal:  Am J Pediatr Hematol Oncol       Date:  1985

Review 5.  [Acquired haemophilia B: a case report and literature review].

Authors:  Inès Jedidi; Sondes Hdiji; Naourez Ajmi; Faiza Makni; Sayda Masmoudi; Moez Elloumi; Choumous Kallel
Journal:  Ann Biol Clin (Paris)       Date:  2011 Nov-Dec       Impact factor: 0.459

6.  Combined factor VIII and IX inhibitors in a girl.

Authors:  C Reussi; R Altman; J Rouvier; R Maino
Journal:  Thromb Diath Haemorrh       Date:  1966-12-01

7.  Circulating IgG antibodies against factors IX and VIII in multiple sclerosis.

Authors:  J L Moake; C J Kent; L D Meta; L C Wright
Journal:  Acta Haematol       Date:  1976       Impact factor: 2.195

8.  Use of porcine factor VIII in the treatment of patients with acquired hemophilia.

Authors:  A E Morrison; C A Ludlam; C Kessler
Journal:  Blood       Date:  1993-03-15       Impact factor: 22.113

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

10.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941

View more
  1 in total

1.  Acquired Hemophilia A: Experience of a Tertiary Care Institute from North India.

Authors:  Narender Kumar; Sweta Rajpal; Jasmina Ahluwalia; Sunil Bose; Varun Uppal; Neelam Varma; Pankaj Malhotra; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2017-09-18       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.